Clostridium Difficile - Articles and news items

Report highlights need for improved management of CDI in IBD patients

Industry news / 11 April 2016 / Victoria White, Digital Content Producer

A current lack of data on outcomes in patients with IBD who have CDI means that appropriate choice of treatment strategy can be unclear…

MGB Biopharma completes Phase I trial of MGB-BP-3

Industry news / 8 December 2015 /

MGB-BP-3 is an antibiotic that is being developed for the potential treatment of Clostridium difficile infections…

Global Clostridium difficile infections market to hit $1.5b by 2024

Industry news / 23 October 2015 / Victoria White

GlobalData says this increase will be driven by the modest uptake of patent-protected, Clostridium difficile infection-specific antibiotics and the arrival of novel non-antibiotic approaches…

Bezlotoxumab reduces C. difficile infection recurrence in Phase 3 trials

Industry news / 21 September 2015 / Victoria White

Merck plans to submit new drug applications seeking regulatory approval of bezlotoxumab in the US, EU and Canada in 2015…

Phase I clinical trial of oral formulation of MGB-BP-3 for treatment of Clostridium Difficile infections begins

Industry news / 21 July 2015 / Victoria White

The first group of healthy volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3…

First patient dosed in the Phase 2 study of SER-109 in recurrent Clostridium difficile infection

Industry news / 28 May 2015 / Victoria White

Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults…

DIFICLIR (fidaxomicin) significantly reduces recurrence and all-cause mortality when used first-line in all patients diagnosed with Clostridium difficile infection (CDI)

Industry news / 21 May 2015 / Victoria White

Data presented from the Clostridium difficile Infection (CDI) Service Evaluation study shows that the adoption pattern of treatment impacts CDI outcomes…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+